ROBB GARY CHARLES (Chief Business Officer) reported 3 transactions at CORCEPT THERAPEUTICS INC
Review the transaction codes below to understand the nature of each event.
Filed: 5/15/2026ACC: 0001193125-26-227411
Officer· Chief Business Officer
Since Mar 2026
-3.30K
Net shares
Net seller
$0.00
Total acquired
0
Open market trades
0B · 0S
3
Total transactions
2K acquired · 5.30K disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
−5.30K
Price / share
—
Trade value
—
% of position
17.8%
5/13/2026
29.79K→24.49K
Common Stock
Indirect
Shares
+1K
Price / share
—
Trade value
—
% of position
8.6%
5/13/2026
11.57K→12.57K
Common Stock
Indirect
Shares
+1K
Price / share
—
Trade value
—
% of position
8.6%
5/13/2026
11.57K→12.57K
Total
Net shares
−3.30K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/13/2026 | G · Gift | −5.30K | — | — | 17.8% | 29.79K | 24.49K |
| Common Stock Indirect | 5/13/2026 | G · Gift | +1K | — | — | 8.6% | 11.57K | 12.57K |
| Common Stock Indirect | 5/13/2026 | G · Gift | +1K | — | — | 8.6% | 11.57K | 12.57K |
| Total | −3.30K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned49.72K
Total
49.72K indirect49.72K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 49.72K | Indirect |
| Total | 49.72K | 49.72K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported